These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3492205)

  • 21. Endothelium-derived relaxing and contracting factors.
    Furchgott RF; Vanhoutte PM
    FASEB J; 1989 Jul; 3(9):2007-18. PubMed ID: 2545495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Release of endothelium-derived relaxing factor (EDRF) from cultured vascular endothelial cells depends on extra- and intracellular Ca2+ concentrations].
    Korenaga R
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):744-54. PubMed ID: 8225180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different patterns of release of endothelium-derived relaxing factor and prostacyclin.
    Mitchell JA; de Nucci G; Warner TD; Vane JR
    Br J Pharmacol; 1992 Feb; 105(2):485-9. PubMed ID: 1373103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.
    Bult H; Fret HR; Van den Bossche RM; Herman AG
    Br J Pharmacol; 1988 Dec; 95(4):1308-14. PubMed ID: 3064856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.
    Stamler JS; Osborne JA; Jaraki O; Rabbani LE; Mullins M; Singel D; Loscalzo J
    J Clin Invest; 1993 Jan; 91(1):308-18. PubMed ID: 8380812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
    Bassenge E
    Eur Heart J; 1991 Nov; 12 Suppl E():12-5. PubMed ID: 1665128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels.
    Cappelli-Bigazzi M; Battaglia C; Pannain S; Chiariello M; Ambrosio G
    J Mol Cell Cardiol; 1997 Mar; 29(3):871-9. PubMed ID: 9152848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Sep; 92(1):181-7. PubMed ID: 3311265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation.
    Mitchell JA; Förstermann U; Warner TD; Pollock JS; Schmidt HH; Heller M; Murad F
    Biochem Biophys Res Commun; 1991 May; 176(3):1417-23. PubMed ID: 1710114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity.
    Mügge A; Elwell JH; Peterson TE; Harrison DG
    Am J Physiol; 1991 Feb; 260(2 Pt 1):C219-25. PubMed ID: 1847583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
    Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
    Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The half-life of endothelium-derived relaxing factor released from bovine aortic endothelial cells in culture.
    Angus JA; Cocks TM
    J Physiol; 1987 Jul; 388():71-81. PubMed ID: 3498834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Wright TF; Tanner MA; Ostlund RE
    J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions.
    Rengasamy A; Johns RA
    J Pharmacol Exp Ther; 1991 Oct; 259(1):310-6. PubMed ID: 1717681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture.
    Cocks TM; Angus JA; Campbell JH; Campbell GR
    J Cell Physiol; 1985 Jun; 123(3):310-20. PubMed ID: 3886674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of guanylate cyclase and inhibition of platelet aggregation by endothelium-derived relaxing factor released from cultured cells.
    Hawkins DJ; Meyrick BO; Murray JJ
    Biochim Biophys Acta; 1988 May; 969(3):289-96. PubMed ID: 2897209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.
    Ignarro LJ; Harbison RG; Wood KS; Kadowitz PJ
    J Pharmacol Exp Ther; 1986 Jun; 237(3):893-900. PubMed ID: 2872327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells.
    White DG; Martin W
    Br J Pharmacol; 1989 Jul; 97(3):683-90. PubMed ID: 2547481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.